3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide

C169H152F6N28O16S3 — CID 157387668

IUPAC3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide
SMILESC=C1C=CC(N2CCOCC2)=CN1c1ccccc1.C=C1C=CC(c2c(C)noc2C)=CN1c1ccc(OC(F)(F)F)cc1.C=C1C=CC(c2c(C)noc2C)=CN1c1ccccc1.C=C1C=CC(c2ccncc2)=CN1c1ccc(OC(F)(F)F)cc1.C=C1C=CC(c2ccncc2)=CN1c1ccccc1.C=C1C=CC(c2cncnc2)=CN1c1ccc(S(N)(=O)=O)cc1.C=C1C=CC(c2cnn(C)c2)=CN1c1ccc(S(N)(=O)=O)cc1.CC(=O)Nc1cccc(-n2cc(-c3c(C)noc3C)ccc2=O)c1.CC(=O)Nc1cccc(-n2cc(-c3cnn(C)c3)ccc2=O)c1.CC(=O)Nc1cccc(-n2cc(-c3nccs3)ccc2=O)c1
InChIInChI=1S/C18H15F3N2O2.C18H13F3N2O.C18H17N3O3.C17H16N4O2.C17H16N2O.C17H14N2.C16H16N4O2S.C16H14N4O2S.C16H13N3O2S.C16H18N2O/c1-11-4-5-14(17-12(2)22-25-13(17)3)10-23(11)15-6-8-16(9-7-15)24-18(19,20)21;1-13-2-3-15(14-8-10-22-11-9-14)12-23(13)16-4-6-17(7-5-16)24-18(19,20)21;1-11-18(12(2)24-20-11)14-7-8-17(23)21(10-14)16-6-4-5-15(9-16)19-13(3)22;1-12(22)19-15-4-3-5-16(8-15)21-11-13(6-7-17(21)23)14-9-18-20(2)10-14;1-12-9-10-15(17-13(2)18-20-14(17)3)11-19(12)16-7-5-4-6-8-16;1-14-7-8-16(15-9-11-18-12-10-15)13-19(14)17-5-3-2-4-6-17;1-12-3-4-13(14-9-18-19(2)10-14)11-20(12)15-5-7-16(8-6-15)23(17,21)22;1-12-2-3-13(14-8-18-11-19-9-14)10-20(12)15-4-6-16(7-5-15)23(17,21)22;1-11(20)18-13-3-2-4-14(9-13)19-10-12(5-6-15(19)21)16-17-7-8-22-16;1-14-7-8-16(17-9-11-19-12-10-17)13-18(14)15-5-3-2-4-6-15/h4-10H,1H2,2-3H3;2-12H,1H2;4-10H,1-3H3,(H,19,22);3-11H,1-2H3,(H,19,22);4-11H,1H2,2-3H3;2-13H,1H2;3-11H,1H2,2H3,(H2,17,21,22);2-11H,1H2,(H2,17,21,22);2-10H,1H3,(H,18,20);2-8,13H,1,9-12H2
InChIKeyBLPUDEJLIQKJOZ-UHFFFAOYSA-N
MW3041.44 g/mol
LogP33.25
Rot. Bonds27

About 3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide

3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide (PubChem CID 157387668) has the molecular formula C169H152F6N28O16S3 and a molecular weight of 3041.44 g/mol. Its IUPAC name is 3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide.

Molecular Properties

Compound Name3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide
PubChem CID157387668
Molecular FormulaC169H152F6N28O16S3
Molecular Weight3041.44 g/mol
Exact Mass3039.10
IUPAC Name3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide
SMILESC=C1C=CC(N2CCOCC2)=CN1c1ccccc1.C=C1C=CC(c2c(C)noc2C)=CN1c1ccc(OC(F)(F)F)cc1.C=C1C=CC(c2c(C)noc2C)=CN1c1ccccc1.C=C1C=CC(c2ccncc2)=CN1c1ccc(OC(F)(F)F)cc1.C=C1C=CC(c2ccncc2)=CN1c1ccccc1.C=C1C=CC(c2cncnc2)=CN1c1ccc(S(N)(=O)=O)cc1.C=C1C=CC(c2cnn(C)c2)=CN1c1ccc(S(N)(=O)=O)cc1.CC(=O)Nc1cccc(-n2cc(-c3c(C)noc3C)ccc2=O)c1.CC(=O)Nc1cccc(-n2cc(-c3cnn(C)c3)ccc2=O)c1.CC(=O)Nc1cccc(-n2cc(-c3nccs3)ccc2=O)c1
InChIInChI=1S/C18H15F3N2O2.C18H13F3N2O.C18H17N3O3.C17H16N4O2.C17H16N2O.C17H14N2.C16H16N4O2S.C16H14N4O2S.C16H13N3O2S.C16H18N2O/c1-11-4-5-14(17-12(2)22-25-13(17)3)10-23(11)15-6-8-16(9-7-15)24-18(19,20)21;1-13-2-3-15(14-8-10-22-11-9-14)12-23(13)16-4-6-17(7-5-16)24-18(19,20)21;1-11-18(12(2)24-20-11)14-7-8-17(23)21(10-14)16-6-4-5-15(9-16)19-13(3)22;1-12(22)19-15-4-3-5-16(8-15)21-11-13(6-7-17(21)23)14-9-18-20(2)10-14;1-12-9-10-15(17-13(2)18-20-14(17)3)11-19(12)16-7-5-4-6-8-16;1-14-7-8-16(15-9-11-18-12-10-15)13-19(14)17-5-3-2-4-6-17;1-12-3-4-13(14-9-18-19(2)10-14)11-20(12)15-5-7-16(8-6-15)23(17,21)22;1-12-2-3-13(14-8-18-11-19-9-14)10-20(12)15-4-6-16(7-5-15)23(17,21)22;1-11(20)18-13-3-2-4-14(9-13)19-10-12(5-6-15(19)21)16-17-7-8-22-16;1-14-7-8-16(17-9-11-19-12-10-17)13-18(14)15-5-3-2-4-6-15/h4-10H,1H2,2-3H3;2-12H,1H2;4-10H,1-3H3,(H,19,22);3-11H,1-2H3,(H,19,22);4-11H,1H2,2-3H3;2-13H,1H2;3-11H,1H2,2H3,(H2,17,21,22);2-11H,1H2,(H2,17,21,22);2-10H,1H3,(H,18,20);2-8,13H,1,9-12H2
InChIKeyBLPUDEJLIQKJOZ-UHFFFAOYSA-N
XLogP33.25
TPSA505.41 Ų
H-Bond Donors5
H-Bond Acceptors40
Rotatable Bonds27
Heavy Atoms222
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003041.44
LogP ≤ 533.25
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1040

Analyze 3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide
CID 161447156
8-[[5-(Benzenesulfonyl)-1,2-oxazol-4-yl]methyl]-2-(3-fluoro-4-piperazin-1-ylanilino)-6-(5-methyl-1,3-thiazol-4-yl)pyrido[2,3-d]pyrimidin-7-one;8-[(2-cyclopentylsulfonylpyrazol-3-yl)methyl]-6-(2-methylphenyl)-2-[4-(1-methylpyrrolidin-3-yl)oxyanilino]pyrido[2,3-d]pyrimidin-7-one;8-[[1-[2-(dimethylamino)ethylsulfonyl]imidazol-2-yl]methyl]-6-(pyridin-3-ylamino)-2-(4-thiomorpholin-2-ylanilino)pyrido[2,3-d]pyrimidin-7-one
CID 157300889

Frequently Asked Questions

What is the IUPAC name of 3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide?
The IUPAC name of 3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide (CID 157387668) is 3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide.
What is the SMILES notation for 3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide?
The canonical SMILES for 3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide is C=C1C=CC(N2CCOCC2)=CN1c1ccccc1.C=C1C=CC(c2c(C)noc2C)=CN1c1ccc(OC(F)(F)F)cc1.C=C1C=CC(c2c(C)noc2C)=CN1c1ccccc1.C=C1C=CC(c2ccncc2)=CN1c1ccc(OC(F)(F)F)cc1.C=C1C=CC(c2ccncc2)=CN1c1ccccc1.C=C1C=CC(c2cncnc2)=CN1c1ccc(S(N)(=O)=O)cc1.C=C1C=CC(c2cnn(C)c2)=CN1c1ccc(S(N)(=O)=O)cc1.CC(=O)Nc1cccc(-n2cc(-c3c(C)noc3C)ccc2=O)c1.CC(=O)Nc1cccc(-n2cc(-c3cnn(C)c3)ccc2=O)c1.CC(=O)Nc1cccc(-n2cc(-c3nccs3)ccc2=O)c1.
What is the InChIKey of 3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide?
The InChIKey is BLPUDEJLIQKJOZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H15F3N2O2.C18H13F3N2O.C18H17N3O3.C17H16N4O2.C17H16N2O.C17H14N2.C16H16N4O2S.C16H14N4O2S.C16H13N3O2S.C16H18N2O/c1-11-4-5-14(17-12(2)22-25-13(17)3)10-23(11)15-6-8-16(9-7-15)24-18(19,20)21;1-13-2-3-15(14-8-10-22-11-9-14)12-23(13)16-4-6-17(7-5-16)24-18(19,20)21;1-11-18(12(2)24-20-11)14-7-8-17(23)21(10-14)16-6-4-5-15(9-16)19-13(3)22;1-12(22)19-15-4-3-5-16(8-15)21-11-13(6-7-17(21)23)14-9-18-20(2)10-14;1-12-9-10-15(17-13(2)18-20-14(17)3)11-19(12)16-7-5-4-6-8-16;1-14-7-8-16(15-9-11-18-12-10-15)13-19(14)17-5-3-2-4-6-17;1-12-3-4-13(14-9-18-19(2)10-14)11-20(12)15-5-7-16(8-6-15)23(17,21)22;1-12-2-3-13(14-8-18-11-19-9-14)10-20(12)15-4-6-16(7-5-15)23(17,21)22;1-11(20)18-13-3-2-4-14(9-13)19-10-12(5-6-15(19)21)16-17-7-8-22-16;1-14-7-8-16(17-9-11-19-12-10-17)13-18(14)15-5-3-2-4-6-15/h4-10H,1H2,2-3H3;2-12H,1H2;4-10H,1-3H3,(H,19,22);3-11H,1-2H3,(H,19,22);4-11H,1H2,2-3H3;2-13H,1H2;3-11H,1H2,2H3,(H2,17,21,22);2-11H,1H2,(H2,17,21,22);2-10H,1H3,(H,18,20);2-8,13H,1,9-12H2.
What are the key properties of 3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide?
3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide has a molecular weight of 3041.44 g/mol, XLogP of 33.25, 27 rotatable bonds, 5 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for 3,5-dimethyl-4-(6-methylidene-1-phenyl-3-pyridinyl)-1,2-oxazole;3,5-dimethyl-4-[6-methylidene-1-[4-(trifluoromethoxy)phenyl]-3-pyridinyl]-1,2-oxazole;N-[3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;4-[2-methylidene-5-(1-methylpyrazol-4-yl)-1-pyridinyl]benzenesulfonamide;4-(6-methylidene-1-phenyl-3-pyridinyl)morpholine;2-methylidene-1-phenyl-5-pyridin-4-ylpyridine;2-methylidene-5-pyridin-4-yl-1-[4-(trifluoromethoxy)phenyl]pyridine;4-(2-methylidene-5-pyrimidin-5-yl-1-pyridinyl)benzenesulfonamide;N-[3-[5-(1-methylpyrazol-4-yl)-2-oxo-1-pyridinyl]phenyl]acetamide;N-[3-[2-oxo-5-(1,3-thiazol-2-yl)-1-pyridinyl]phenyl]acetamide is sourced from PubChem (CID 157387668), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).